Showing results (61-70 of 154) with videos related to
Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytesJ J Weis, T F Tedder, D T FearonJournal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
Characterization of human T lymphocytes that express the C3b receptorJ G Wilson, T F Tedder, D T FearonJournal of Immunology (Baltimore, Md. : 1950)|August 1, 1976
C3 requirements for formation of alternative pathway C5 convertaseM R Daha, D T Fearon, K F AustenKidney International|August 1, 1984
Biocompatibility of dialysis membranes: effects of chronic complement activationR M Hakim, D T Fearon, J M LazarusImmunology|November 1, 1976
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved BM R Daha, D T Fearon, K F AustenProceedings of the National Academy of Sciences of the United States of America|December 1, 1978
Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathwayU E Nydegger, D T Fearon, K F AustenThe Journal of Allergy and Clinical Immunology|October 1, 1979
Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedemaA L Sheffer, D T Fearon, K F AustenJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1979
Action of the C3b-inactivator on the cell-bound C3bS K Law, D T Fearon, R P LevineAnnals of Internal Medicine|March 1, 1977
Methyltestosterone therapy in hereditary angioedemaA L Sheffer, D T Fearon, K F AustenImmunity|July 1, 1997
Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulinR M Tooze, G M Doody, D T FearonPageof 16